E-LIB Suche - Ergebnisse für: Surie, Diya

1

Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COV..:

Ma, Kevin C ; Surie, Diya ; Lauring, Adam S...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Antigenic Characterization of Circulating and Emerging SARS..:

Di, Han ; Pusch, Elizabeth A. ; Jones, Joyce...
Vaccines. 12 (2024) 5 - p. 505 , 2024

Link: https://doi.org/10.3390/..

3

SARS-CoV-2 shedding and evolution in patients who were immu..:

Raglow, Zoe ; Surie, Diya ; Chappell, James D...
The Lancet Microbe. 5 (2024) 3 - p. e235-e246 , 2024

Link: https://doi.org/10.1016/..

4

Fungal Pathogens as Causes of Acute Respiratory Illness in ..:

Caceres, Diego H. ; Rodriguez-Barradas, Maria C. ; Whitaker, Michael...
Journal of Fungi. 9 (2023) 4 - p. 456 , 2023

Link: https://doi.org/10.3390/..

5

Comparison of mRNA vaccine effectiveness against COVID-19-a..:

Surie, Diya ; Bonnell, Levi N. ; DeCuir, Jennifer...
Vaccine. 41 (2023) 29 - p. 4249-4256 , 2023

Link: https://doi.org/10.1016/..

6

Disease Severity of Respiratory Syncytial Virus Compared wi..:

Surie, Diya ; Yuengling, Katharine A. ; DeCuir, Jennifer...
MMWR. Morbidity and Mortality Weekly Report. 72 (2023) 40 - p. 1083-1088 , 2023

Link: https://doi.org/10.15585..

7

1108. Severity of Illness among Adults Hospitalized with Re..:

Yuengling, Katharine ; Surie, Diya ; DeCuir, Jennifer...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

2083. Waning of Bivalent mRNA Vaccine Effectiveness Against..:

DeCuir, Jennifer ; Zhu, Yuwei ; Gaglani, Manjusha...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

9

1097. A Prospective Evaluation of SARS-CoV-2 Shedding and E..:

Raglow, Zoe M ; Surie, Diya ; Chappell, James...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

10

Response to Comment: Absolute and Relative Vaccine Effectiv..:

Lewis, Nathaniel M ; Rhoads, Jillian P ; Self, Wesley H.
Open Forum Infectious Diseases. 10 (2023) 5 - p. , 2023

Link: https://doi.org/10.1093/..

11

Isoniazid-associated pellagra during mass scale-up of tuber..:

Nabity, Scott A ; Mponda, Kelvin ; Gutreuter, Steve...
The Lancet Global Health. 10 (2022) 5 - p. e705-e714 , 2022

Link: https://doi.org/10.1016/..

12

Tuberculosis attributed to transmission within healthcare f..:

Smith, Jonathan P. ; Modongo, Chawangwa ; Moonan, Patrick K....
Infection Control & Hospital Epidemiology. 43 (2022) 11 - p. 1603-1609 , 2022

Link: https://doi.org/10.1017/..

13

Neutralizing antibody responses in patients hospitalized wi..:

Linderman, Susanne L. ; Lai, Lilin ; Bocangel Gamarra, Estefany L....
Journal of Clinical Investigation. 132 (2022) 23 - p. , 2022

Link: https://doi.org/10.1172/..

14

Absolute and Relative Vaccine Effectiveness of Primary and ..:

Lewis, Nathaniel M ; Murray, Nancy ; Adams, Katherine...
Open Forum Infectious Diseases. 10 (2022) 1 - p. , 2022

Link: https://doi.org/10.1093/..

15

Vaccine effectiveness of primary series and booster doses a..:

Adams, Katherine ; Rhoads, Jillian P ; Surie, Diya...
BMJ. , 2022

Link: https://doi.org/10.1136/..